✨ Free AI Report
Tabuk Pharmaceuticals: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Tabuk Pharmaceuticals
Company Research

Tabuk Pharmaceuticals: Business Overview, Financials & Competitive Analysis

Tabuk Pharmaceuticals scores 7/10 on the AskCyborg Cyborg Score (Strong). Established regional pharma leader with dominant Saudi positioning and scaled manufacturing, well-positioned for MENA healthcare expansion and Vision 2030 alignment. Tabuk holds the #1 position in Saudi private pharma and #2 in MENA generics, with established manufacturing scale (2+ billion units/year), regional footprint (17 countries), and R&D capabilities. Revenue ($72M.

What is Tabuk Pharmaceuticals's industry? Tabuk Pharmaceuticals (tabukpharma.com) operates in Generic Drugs. AskCyborg classifies Tabuk Pharmaceuticals under Generic Drugs in its company registry.

Tabuk Pharmaceuticals, established in 1994 and headquartered in Riyadh, is the largest privately-owned pharmaceutical company in Saudi Arabia, with a strong market presence throughout the Middle East and North Africa ...

7/ 10Strong

Cyborg Score thesis

Established regional pharma leader with dominant Saudi positioning and scaled manufacturing, well-positioned for MENA healthcare...

Read the full analyst-debate transcript →
Industry Generic Drugs
5 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Tabuk Pharmaceuticals Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Tabuk Pharmaceuticals

AskCyborg analysts argue the bull and bear cases for Tabuk Pharmaceuticals across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Tabuk Pharmaceuticals OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Tabuk Pharmaceuticals Overview

Pro stress-test →

Tabuk Pharmaceuticals, established in 1994 and headquartered in Riyadh, is the largest privately-owned pharmaceutical company in Saudi Arabia, with a strong market presence throughout the Middle East and North Africa (MENA) region. The company manufactures and distributes a wide range of pharmaceutical products, addressing various therapeutic fields, including central nervous, cardiovascular, respiratory, musculoskeletal, gastrointestinal systems, and anti-infectives.

Strategic Profile

Pro stress-test →

As the leading company in the Saudi private market and the second leading generic in MENA, Tabuk Pharmaceuticals is delivering on its commitment to promoting well-being and consistently enhancing healthcare outcomes. The company is a fully owned subsidiary of Astra Industrial Group, a publicly traded company on the Saudi stock exchange. Its manufacturing sites produce over 2 billion base units annually to help maintain the health of millions of patients across 17 countries in the MENA region.

Competitive Landscape

Pro stress-test →

Tabuk competes in the MENA generic and branded generic pharmaceutical market alongside international and regional players. Direct competitors include regional generic manufacturers and multinational pharma companies with presence in Saudi Arabia and the Gulf. The competitive positioning reflects consolidation around branded generics and therapeutic specialization, where Tabuk's scale and regional distribution network provide advantages against smaller pure-play generics and disadvantages against larger integrated multinationals in innovation velocity.

Industry Context

Tabuk Pharmaceuticals operates in Generic Drugs.

Key facts

Founded: 1994 · Headquarters: Riyadh, Saudi Arabia · Employees: 2,400 · Revenue: $72M

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Tabuk Pharmaceuticals.

  • Leading player in Saudi private pharmaceutical market and second-largest generic player in MENA
  • Manufacturing capacity exceeds 2 billion base units annually across four sites in Saudi Arabia, Sudan, and Algeria
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • December 2025Partnership with Althera Laboratories for Type 2 Diabetes combination therapy distribution in MENA
  • September 2025Specialty pharmaceutical partnership with Vibativ® for pneumonia and skin infection treatment
  • +2 moreTrack every material event for Tabuk Pharmaceuticals as it happens. Explore monitoring →
Get alerted when Tabuk Pharmaceuticals has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Sanofi Middle EastGlobal pharma with significant MENA generic and specialty presence→Pfizer Middle EastMultinational pharmaceutical company competing in MENA generics and specialty drugs→AstraZeneca Middle EastMajor global pharma with regional MENA operations→Al-Razi Pharma IndustriesSaudi generic pharmaceutical manufacturer serving GCC region with SFDA cGMP certification→Zahra PharmaRegional generic drug manufacturer providing affordable pharmaceuticals→

Compare Tabuk Pharmaceuticals with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Tabuk Pharmaceuticals operates in Generic Drugs. See how the rest of the sector scores on the Cyborg framework.

Browse Generic Drugs research →
NEW · MCP server

Ask your AI assistant about Tabuk Pharmaceuticals

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Tabuk Pharmaceuticals and its top competitor on Cyborg Score”
“What did Tabuk Pharmaceuticals do this quarter?”
“Is Tabuk Pharmaceuticals a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Tabuk Pharmaceuticals do?+
Tabuk Pharmaceuticals, established in 1994 and headquartered in Riyadh, is the largest privately-owned pharmaceutical company in Saudi Arabia, with a strong market presence throughout the Middle East and North Africa ...
What is Tabuk Pharmaceuticals's Cyborg Score?+
Tabuk Pharmaceuticals has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Tabuk Pharmaceuticals's main competitors?+
Named competitors include Sanofi Middle East, Pfizer Middle East, AstraZeneca Middle East, Al-Razi Pharma Industries. The full competitive landscape is in the AskCyborg report.
How can I get the full Tabuk Pharmaceuticals research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Tabuk Pharmaceuticals research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Tabuk Pharmaceuticals over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.